Journal of Clinical Oncology, Vol 24, No 6 (February 20), 2006: pp. 884-890
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.02.4505
White Matter Anisotropy in Post-Treatment Childhood Cancer Survivors: Preliminary Evidence of Association With Neurocognitive Function
Pek-Lan Khong,
Lucullus H.T. Leung,
Amy S.M. Fung,
Daniel Y.T. Fong,
Deqiang Qiu,
Dora L.W. Kwong,
Gaik-Cheng Ooi,
Grainne McAlanon,
Guang Cao,
Godfrey C.F. Chan
From the Departments of Diagnostic Radiology, Clinical Oncology, Clinical Psychology, Nursing Studies, Psychiatry, Paediatric and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong; GE Medical Systems Asia, Hong Kong, China
Address reprint requests to Pek-Lan Khong, Department of Diagnostic Radiology, Blk K, Rm 406, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Rd, Hong Kong; e-mail: plkhong{at}hkucc.hku.hk
PURPOSE: We aim to determine if the loss of white matter fractional anisotropy (FA), measured by diffusion tensor magnetic resonance imaging (DTI), in post-treatment childhood medulloblastoma (MED) and acute lymphoblastic leukemia (ALL) survivors correlate with intelligence quotient (IQ) scores.
MATERIALS AND METHODS: MED and ALL survivors (n = 30; 20 male, 10 female; age range, 6.0 to 22.1 years; mean, 13.1 years) were recruited for DTI and IQ tests. In this cross-sectional study, age-matched normal control (n = 55; 32 male, 23 female; age range, 6.0 to 23 years; mean, 12.1 years) DTI was obtained to compute percentage difference in white matter FA ( FA%) for each patient compared with the age-matched control group. Multivariate regression analysis was performed to determine the relationships between FA%, age at treatment, irradiation dose, time interval from treatment, and full-scale IQ (FSIQ), verbal IQ (VIQ), and performance IQ (PIQ). Receiver operating characteristics curves were used to determine the best FA% cutoffs for predicting FSIQ, VIQ, and PIQ of less than 85.
RESULTS: FA% had a significant effect on FSIQ (adjusted r2 = 0.439; P < .001), VIQ (adjusted r2 = 0.237; P = .028), and PIQ (adjusted r2 = 0.491; P < .001) after adjusting for the effects of age at treatment, irradiation dose, and time interval from treatment. The best FA% value to predict less than 85 scores in FSIQ, VIQ, and PIQ was 3.3% with specificities of 100% and sensitivities ranging from 77.8% to 87.5%.
CONCLUSION: Our preliminary findings suggest that white matter FA may be a clinically useful biomarker for the assessment of treatment-related neurotoxicity in post-treatment childhood cancer survivors.
Supported by Hong Kong RGC CERG Grant Ref: HKU 7416/03M.
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W.E. Reddick, J.O. Glass, D.P. Johnson, F.H. Laningham, and C.-H. Pui
Voxel-Based Analysis of T2 Hyperintensities in White Matter during Treatment of Childhood Leukemia
AJNR Am. J. Neuroradiol.,
November 1, 2009;
30(10):
1947 - 1954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.C. Sundgren
MR Spectroscopy in Radiation Injury
AJNR Am. J. Neuroradiol.,
September 1, 2009;
30(8):
1469 - 1476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wang, E. X. Wu, D. Qiu, L. H.T. Leung, H.-F. Lau, and P.-L. Khong
Longitudinal Diffusion Tensor Magnetic Resonance Imaging Study of Radiation-Induced White Matter Damage in a Rat Model
Cancer Res.,
February 1, 2009;
69(3):
1190 - 1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Provenzale
Advances in Pediatric Neuroradiology: Highlights of the Recent Medical Literature
Am. J. Roentgenol.,
January 1, 2009;
192(1):
19 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Askins and B. D. Moore III
Preventing Neurocognitive Late Effects in Childhood Cancer Survivors
J Child Neurol,
October 1, 2008;
23(10):
1160 - 1171.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wick, R. Stupp, A.-C. Beule, J. Bromberg, A. Wick, U. Ernemann, M. Platten, C. Marosi, W. P. Mason, M. van den Bent, et al.
A novel tool to analyze MRI recurrence patterns in glioblastoma
Neuro-oncol,
January 1, 2008;
10(6):
1019 - 1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Waber, J. Turek, L. Catania, K. Stevenson, P. Robaey, I. Romero, H. Adams, C. Alyman, C. Jandet-Brunet, D. S. Neuberg, et al.
Neuropsychological Outcomes From a Randomized Trial of Triple Intrathecal Chemotherapy Compared With 18 Gy Cranial Radiation As CNS Treatment in Acute Lymphoblastic Leukemia: Findings From Dana-Farber Cancer Institute ALL Consortium Protocol 95-01
J. Clin. Oncol.,
November 1, 2007;
25(31):
4914 - 4921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Palmer, W. E. Reddick, and A. Gajjar
Understanding the Cognitive Impact on Children Who are Treated for Medulloblastoma
J. Pediatr. Psychol.,
October 1, 2007;
32(9):
1040 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Ris
Lessons in Pediatric Neuropsycho-Oncology: What We Have Learned Since Johnny Gunther
J. Pediatr. Psychol.,
October 1, 2007;
32(9):
1029 - 1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mark Mahone, M. Cristine Prahme, K. Ruble, S. H. Mostofsky, and C. L. Schwartz
Motor and Perceptual Timing Deficits Among Survivors of Childhood Leukemia
J. Pediatr. Psychol.,
September 1, 2007;
32(8):
918 - 925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Mabbott, M. D. Noseworthy, E. Bouffet, C. Rockel, and S. Laughlin
Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: Correlation with IQ
Neuro-oncol,
July 1, 2006;
8(3):
244 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|